MENA Orders Secured, Expanded & Operations Unaffected
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Memphasys Ltd reports that its operations in the Middle East and North Africa remain unaffected by regional conflicts, with ongoing commercial activities and new orders secured in various countries. The company highlights that its established operations in Qatar continue to thrive, while new partnerships in Egypt and Turkey are progressing towards market entry. Memphasys has received new orders from customers in the UAE and Iraq, indicating strong demand for its Felix™ System across the region. The filing outlines the company's resilient commercial strategy, which focuses on diversified customer engagement and maintaining supply chain flexibility.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Memphasys
- Appendix 4D - Half-year Financial Report - 31 December 2025
- Memphasys Secures TGA Approval for Felix System
- Memphasys announces successful $800,000 Capital Raising
- Trading Halt
- Regulatory Submissions Lodged for Felix
Later from Memphasys
- Investor Presentation - April 2026
- Quarterly Activities/Appendix 4C Cash Flow Report
- ITL Orders 1000 Felix Cartridges Across MENA Markets
- South-East Asian Commercialization Agreement Secured
- Memphasys Executes Supply Agreement with Monash IVF Group
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys